FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Axium Healthcare Pharmacy dba Balanced Solutions Compounding 17 Alpha Hydroxyprogesterone Caproate Recall

17 Alpha Hydroxyprogesterone Caproate Injectable Balanced Solutions, Compounding Pharm…

Axium Healthcare Pharmacy dba Balanced Solutions Compounding · Lake Mary, FL

Risk level
Class II
Reported by FDA
May 1, 2013
Recall ID
D-286-2013
Check your lot numberHow we source this data

Summary

Axium Healthcare Pharmacy dba Balanced Solutions Compounding recalled 17 Alpha Hydroxyprogesterone Caproate starting Apr 17, 2013. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-286-2013 on May 1, 2013. Reason: Lack of Assurance of Sterility:All sterile products compounded, repackaged, and distributed by this compounding pharmacy due to lack of sterility assurance and concerns associated with the quality control processes. Status: Terminated.

Why it was recalled

Lack of Assurance of Sterility:All sterile products compounded, repackaged, and distributed by this compounding pharmacy due to lack of sterility assurance and concerns associated with the quality control processes.

Product description

17 Alpha Hydroxyprogesterone Caproate Injectable Balanced Solutions, Compounding Pharmacy a division of Axium Healthcare Pharmacy, Inc., Lake Mary, FL 32746

Lot numbers, UPCs & expiration codes

ALL Lots

Where it was sold

CO, GA, MI, and Puerto Rico

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-286-2013
Classification
Class II
Status
Terminated
Recall initiated
Apr 17, 2013
FDA report date
May 1, 2013
Quantity
4 vials (5 mL each)
Recall type
Voluntary: Firm initiated
Recalling firm
Axium Healthcare Pharmacy dba Balanced Solutions Compounding

Original FDA data

Every field from FDA enforcement report D-286-2013, exactly as published.

Show all FDA fields
City
Lake Mary
State
FL
Status
Terminated
Country
United States
Event ID
64957
Address
550 Technology Park Ste 1008
Code information
ALL Lots
Postal code
32746-7131
Report date
May 1, 2013
Product type
Drugs
Recall number
D-286-2013
Classification
Class II
Recalling firm
Axium Healthcare Pharmacy dba Balanced Solutions Compounding
Product quantity
4 vials (5 mL each)
Termination date
Apr 19, 2017
Reason for recall
Lack of Assurance of Sterility:All sterile products compounded, repackaged, and distributed by this compounding pharmacy due to lack of sterility assurance and concerns associated with the quality control processes.
Voluntary / mandated
Voluntary: Firm initiated
Product description
17 Alpha Hydroxyprogesterone Caproate Injectable Balanced Solutions, Compounding Pharmacy a division of Axium Healthcare Pharmacy, Inc., Lake Mary, FL 32746
Distribution pattern
CO, GA, MI, and Puerto Rico
Recall initiation date
Apr 17, 2013
Initial firm notification
Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Center classification date
Apr 23, 2013

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-286-2013, published May 1, 2013. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls